Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/26/2012 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Thom Segerson?

Thom Segerson

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Advisory Board Member

Health Impact Fund


Vice President for Medical and Scientific Affairs

Bayer HealthCare AG


Assistant Professor of Medicine

Oregon Health & Science University


Faculty

Oregon Health & Science University


Internist and Endocrinologist

AcademicStand Subscribe


Faculty

Vollum Institute


Web References(10 Total References)


www.healthimpactfund.org

Thom Segerson, Consultant
Thom Segerson Thom Segerson is an internist and endocrinologist with a background in academic and pharmaceutical medicine. He received his MD at the University of Kansas, and trained in Internal Medicine at the Medical College of Wisconsin and Endocrinology at Tufts-New England Medical Center. He was on faculty at Tufts Medical School in Boston and Oregon Health and Science University and the Vollum Institute, both in Portland, OR. He spent nearly 13 years with Bayer Healthcare, located in the US, Canada, Mexico City and Berlin, where he was successively responsible for global clinical development and the medical organizations of Canada, Latin America, Europe, Central Asia, Middle East and Africa. To extend his focus on the promotion of equitable access to healthcare technologies through alignment of development and delivery to the most compelling health needs, Thom is currently enrolled in the Master's program at the Johns Hopkins Bloomberg School of Public Health, with a focus in Public Health Policy. (top)


academicsstand.org

Thom Segerson
Thom Segerson is an internist and endocrinologist with a background in academic and pharmaceutical medicine. He received his MD at the University of Kansas, and trained in Internal Medicine at the Medical College of Wisconsin and Endocrinology at Tufts-New England Medical Center. He was on faculty at Tufts Medical School in Boston and Oregon Health and Science University and the Vollum Institute, both in Portland, OR. He spent nearly 13 years with Bayer Healthcare, located in the US, Canada, Mexico City and Berlin, where he was successively responsible for global clinical development and the medical organizations of Canada, Latin America, Europe, Central Asia, Middle East and Africa. To extend his focus on the promotion of equitable access to healthcare technologies through alignment of development and delivery to the most compelling health needs, Thom is currently enrolled in the Master's program at the Johns Hopkins Bloomberg School of Public Health, with a focus in Public Health Policy.


biz.yahoo.com [cached]

Levitra's developers believe "the magnitude of the effect is of no clinical consequence," Dr. Thomas Segerson, Bayer Canada's vice president for medical and scientific affairs, told the panel. Email this story - Set a News Alert


www.lscds.org [cached]

1) Thom Segerson (M.D.)
Pharmaceuticals Division, Bayer HealthCare Dr. Thomas Segerson is the Vice President, Medical and Scientific Affairs, Pharmaceuticals Division of Bayer HealthCare in Canada. He is responsible for the Regulatory, Scientific Development, Clinical Operations, Clinical Product Development, and Drug Safety and Medical Information functions. Prior to joining the Canadian organization in 2003, Dr. Segerson held progressive positions within Bayer Corporation in the United States including Global Clinical Project Leader for the registration of Levitra, Associate Director, and Deputy Director within the Metabolics Division of Medical Affairs. Dr. Segerson's extensive and diverse experience in the healthcare industry also encompasses a position as an Assistant Professor of Medicine at Oregon Health Sciences University in Portland, Oregon where he specialized in basic and clinical endocrine research. In addition, Dr. Segerson trained in Clinical Endocrinology at Tufts University Medical School, in Internal Medicine at the Medical College of Wisconsin, and is a graduate from the University of Kansas, School of Medicine.


www.heartcenteronline.com [cached]

Bayer and GlaxosmithKline believe the QT effect seen with Levitra "is of no clinical consequence," Dr. Thomas Segerson, Bayer Canada's vice president for medical and scientific affairs, told the panel.


Similar Profiles

Other People with this Name

Other People with the name Segerson

Sebreta Segerson

Dance Co.

Lisa Segerson

Thunderbolt Utility Contractors , Inc.

Cassie Segerson

Thunderbolt Utility Contractors Inc

Philip Segerson

Thunderbolt Utility Contractors , Inc.

Keith Segerson

P3 Innovation Strategies LLC

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory